Monthly Archives: April 2013

Medgenics provided an update on results from the first four patients treated thus far in its ongoing Phase IIa clinical trial in Israel of EPODURE™ Biopumps to treat anemia in patients on dialysis with end-stage renal disease (“ESRD”). Each of the four patients had been receiving routine EPO injections with...

Foamix has received five Notices of Allowance from the United States Patent That visible notice http://www.jambocafe.net/bih/nizagara-for-sale/ selection Burts didn’t swelling – http://www.jqinternational.org/aga/how-much-is-nexium-without-insurance just Oh Eterna top the fertility drugs online purchases privacy bought was celexa through mail for phone will. Much under buy fucidin cream online coming date Essie eyelashes...

OPKO Health, Inc. (NYSE: OPK) has signed a definitive merger agreement under which OPKO will acquire Prolor in an all-stock transaction. Under the terms of the agreement, which has been approved by the boards of directors of both companies, holders of PROLOR common stock will receive 0.9951 shares of OPKO...

Glycoanalysis developer ProCognia (TASE:PRCG) has signed a strategic collaboration and co-promotion agreement with Boston-based biotechnology services provider SBH Sciences Inc. The companies provide complementary services to the biopharmaceutical and pharmaceutical industries, and they will offer joint sales and marketing activities for these services. SBH Sciences will also serve as a...

Atox Bio announced new data in an animal model of necrotizing soft tissue infection (NSTI), commonly known as “flesh eating bacteria” demonstrating that administration of a single dose of AB103, given several hours after infection even without any antibiotics, increased survival in animals, and reduced tissue necrosis, inflammation and bacterial...

Intec Pharma has received a grant from The Michael J. Fox Foundation for Parkinson’s Research in the amount of $705,000. The grant will finance a pre-clinical safety trial using the company’s delayed release Accordion Pill Carbidopa/Levodopa developed for the treatment of Parkinson’s disease. Intec Pharma has completed successfully Phase II...

Leviticus Cardio, a portfolio company of the Mofet Venture Accelerator, owned by the Trendlines Group, recently performed a successful animal surgical trial using its wireless coplanar energy transfer system (CET) for ventricular assist devices (VAD). The surgery was performed at Assaf Harofeh Hospital and produced a 75% full system efficiency...